Mon. May 25th, 2026
Spread the love

The Federal High Court, Abuja, has given the Independent National Electoral Commission(INEC), permission to proceed with its planned recall of Sen. Dino Melaye (APC-Kogi).

Justice Nnamdi Dimgba gave INEC the permission to go ahead with the process on Monday after dismissing Melaye’s suit for lacking merit.

Melaye had filed a suit seeking to stop INEC from recalling him from the Senate following a petition it received from the constituents of Kogi West Senatorial District, which Melaye represents.

Dimgba, in his judgment, premised his opinion on the grounds that Melaye was hasty to run to the court and that he should have explored and exhausted the internal mechanisms provided by the 1999 Constitution.

According to the judge, “Melaye’s complaints are hasty, premature and presumptuous.’’

He therefore ordered INEC to go ahead with its planned verification of signatures contained in the petition.

The judge, however, ordered INEC to furnish Melaye with a copy of the petition it received, a schedule of the signatories and a full list of persons in support of the recall petition.

The judge held that the constituents who wrote the petition to INEC seeking his recall were not under any duty to serve him with a copy of the petition or offer him an opportunity to defend himself.

“I do not believe that the petitioners have the duty to serve the plaintiff with a copy of the petition. The duty of the constituents is to write and submit their petition to the electoral body.

“There is no provision in Sections 68 and 69 of the Constitution that provides the scope for the writers of the petition to inform the plaintiff of plans to recall him or for him to come and clear himself of allegations levelled against him.

The trial judge held that the only option available for Melaye, was for him to go through the verification process to be conducted by INEC.

He further held that it was only when Melaye noticed any infraction, fake signatures or names of dead persons during the verification exercise that he could approach the court to seek redress.

On the 90 days time limit set for the recall process, the court said it was doubtful of the date beginning from June 23, 2017.

He said even if it existed; the 90 days paused on July 6, 2017 when the court made an interim order on the suit.

“Ordinarily, the 90 days begins today that this pronouncement has been made.”

Melaye had among other reliefs prayed the court to declare that the petition his constituents presented to INEC for his recall was illegal, unlawful, invalid, null and void and of no effect in law.

He had further prayed the court to declare the petition invalid and of no effect, on the grounds that it was signed by fictitious, dead and non existing persons in his senatorial district.

He also contested that the recall was invalid because he was not served a copy of the petition and that not serving him a copy of the petition violated his rights to fair hearing as well as natural justice.

A sister suit filed by the All Progressives Congress (APC) seeking the nullification of the recall process was also dismissed. 

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.